175 related articles for article (PubMed ID: 19834456)
21. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.
Li S; Sonenberg N; Gingras AC; Peterson M; Avdulov S; Polunovsky VA; Bitterman PB
Mol Cell Biol; 2002 Apr; 22(8):2853-61. PubMed ID: 11909977
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
Apoptosis; 2010 Jul; 15(7):795-804. PubMed ID: 20221697
[TBL] [Abstract][Full Text] [Related]
23. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
Kodali D; Rawal A; Ninan MJ; Patel MR; Mesa H; Knapp D; Schnitzer B; Kratzke RA; Gupta P
Arch Pathol Lab Med; 2011 Mar; 135(3):365-71. PubMed ID: 21366462
[TBL] [Abstract][Full Text] [Related]
24. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
[TBL] [Abstract][Full Text] [Related]
25. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.
Hsu HS; Lin MH; Jang YH; Kuo TT; Liu CC; Cheng TH
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):378-85. PubMed ID: 25439783
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1.
Azar R; Najib S; Lahlou H; Susini C; Pyronnet S
Cell Mol Life Sci; 2008 Oct; 65(19):3110-7. PubMed ID: 18810319
[TBL] [Abstract][Full Text] [Related]
27. 4E-BP1, a multifactor regulated multifunctional protein.
Qin X; Jiang B; Zhang Y
Cell Cycle; 2016; 15(6):781-6. PubMed ID: 26901143
[TBL] [Abstract][Full Text] [Related]
28. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1.
Averous J; Fonseca BD; Proud CG
Oncogene; 2008 Feb; 27(8):1106-13. PubMed ID: 17724476
[TBL] [Abstract][Full Text] [Related]
30. Suppression of translation during in vitro maturation of pig oocytes despite enhanced formation of cap-binding protein complex eIF4F and 4E-BP1 hyperphosphorylation.
Ellederova Z; Kovarova H; Melo-Sterza F; Livingstone M; Tomek W; Kubelka M
Mol Reprod Dev; 2006 Jan; 73(1):68-76. PubMed ID: 16211600
[TBL] [Abstract][Full Text] [Related]
31. alpha(1A) adrenergic receptor induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca(2+)-dependent pathway independent of phosphatidylinositol 3-kinase/Akt.
Rybkin II; Cross ME; McReynolds EM; Lin RZ; Ballou LM
J Biol Chem; 2000 Feb; 275(8):5460-5. PubMed ID: 10681523
[TBL] [Abstract][Full Text] [Related]
32. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
[TBL] [Abstract][Full Text] [Related]
33. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.
She QB; Halilovic E; Ye Q; Zhen W; Shirasawa S; Sasazuki T; Solit DB; Rosen N
Cancer Cell; 2010 Jul; 18(1):39-51. PubMed ID: 20609351
[TBL] [Abstract][Full Text] [Related]
34. Ablation of 4E-BP1/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture.
Schrufer TL; Antonetti DA; Sonenberg N; Kimball SR; Gardner TW; Jefferson LS
Diabetes; 2010 Sep; 59(9):2107-16. PubMed ID: 20547975
[TBL] [Abstract][Full Text] [Related]
35. Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes.
Huang BP; Wang Y; Wang X; Wang Z; Proud CG
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H505-14. PubMed ID: 19074679
[TBL] [Abstract][Full Text] [Related]
36. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
37. Stabilization of 4E-BP1 by PI3K kinase and its involvement in CHK2 phosphorylation in the cellular response to radiation.
Yu ZJ; Luo HH; Shang ZF; Guan H; Xiao BB; Liu XD; Wang Y; Huang B; Zhou PK
Int J Med Sci; 2017; 14(5):452-461. PubMed ID: 28539821
[No Abstract] [Full Text] [Related]
38. Macrophage inflammatory protein-1alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1.
Aronica SM; Gingras AC; Sonenberg N; Cooper S; Hague N; Broxmeyer HE
Blood; 1997 May; 89(10):3582-95. PubMed ID: 9160663
[TBL] [Abstract][Full Text] [Related]
39. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Ding M; Van der Kwast TH; Vellanki RN; Foltz WD; McKee TD; Sonenberg N; Pandolfi PP; Koritzinsky M; Wouters BG
Mol Cancer Res; 2018 Apr; 16(4):682-695. PubMed ID: 29453322
[TBL] [Abstract][Full Text] [Related]
40. The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency.
Magagnin MG; van den Beucken T; Sergeant K; Lambin P; Koritzinsky M; Devreese B; Wouters BG
Proteomics; 2008 Mar; 8(5):1019-28. PubMed ID: 18219697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
